Invest in SanMelix

SanMelix is a bioactive skin and wound care company using the natural healing properties of Buckwheat honey, combined with our advanced bioactive enhancements. SanMelix has created products that aid in the healing of acute, chronic, and minor wounds. Our goal is to enhance our market position in the global Skin and Wound Care market.

BEECure™ M is not currently available on the market. This product is pending 510(k) submission.

In light of the current Covid-19 Pandemic, there has been a rise in healthcare admissions and an increased awareness of infection control. With IP protection on our BEECure™ M dressing and other pending patents, co-created by a renowned Harvard trained podiatric physician, SanMelix's advanced bioactive skin and wound care products can be used in a host of settings and situations. With the CDC investing $300M+ in 59 state & local health departments to detect and prevent resistant threats, our advanced wound care dressings are ideal for HealthCare Associated Infections (HAIs) and the Antimicrobial Resistance (AR) crisis by reducing microbial growth to prevent life threatening bacteria (e.g. MRSA) from penetrating the dressing while in use.

Our goal is to improve the lives of patients and help speed up the healing process using the natural therapeutic properties that already exist in buckwheat honey. Honey has been used in medicine since 8000 BC because of its unique healing properties and with our team of doctors and scientists, we have enhanced it through the use of broad-spectrum antimicrobials. Dr. Sabacinski has been working in the wound care space for over thirty years, and he knows the patients’ needs for a product that encourages fast wound closure and provides protection from bacteria and infection. Our mission at SanMelix is to help people live happier, healthier lives by providing fast and effective wound and skin care through superior natural remedies. We want to give caregivers, physicians, and the general public the ability to heal wounds using a natural product that has been used for centuries. At SanMelix, the proof is in our buckwheat honey. 

The entire population requires wound care

• Global Skin and Wound Care Market Is Expected to Reach USD 25.98 Billion by 2025
• 50 million people annually are affected by hard to close wounds worldwide
• A failure to address the problem of the Antimicrobial Resistance (AR) could result in 10 million people dying per year by 2050.
• Chronic wounds affect over 5.7 million patients in the U.S. alone and are estimated to cost $20 billion annually, thus impacting the market growth positively 

• Each year, about 1 in 25 U.S. hospital patients is diagnosed with at least one infection related to hospital care alone; additional infections occur in other healthcare settings
• Everyday people require wound care therapies for minor burns, cuts, scrapes, abrasions, and rashes 
• Of the 3 million patients in the United States receiving radiation 85% experience moderate to severe skin reactions. 

Human wounds and its burden

• Many Healthcare Associated Infections HAIs are caused by the most urgent and serious antibiotic-resistant (AR) bacteria and may lead to sepsis or death.
• Up to one-third of the half billion people with diabetes worldwide will develop a diabetic foot ulcer (DFU). Of these, 17% will require an amputation. 
• There are few effective therapies for radiotherapy, laser therapy and minor thermal burns

Using buckwheat honey products, we can solve them

• Our BEECure™ M (buckwheat honey MGO) patented formulation prevents HAI’s by reducing microbial growth to prevent life threatening bacteria (MRSA) from penetrating the dressing while in use
• Case studies using BEECure™ M illustrated accelerated healing and skin regeneration on severe limb threatening wounds
• Our BEECure™ R was developed with buckwheat honey and calming calendula that soothes, hydrates, and revives skin affected by radiation and laser therapy, as well as those exposed to heat and sun. 

We create products using Buckwheat Honey

We are focusing on the unique medicinal properties of Buckwheat Honey for tissue regeneration and accelerated healing. Our bioactive buckwheat honey formulations demonstrate intrinsic healing activity with anti-microbial additives to prevent infection. SanMelix has created and will continue to create products utilizing Buckwheat honey. SanMelix currently has two patents on its BEECure™ M formulation and Dr. Sabacinski has co-invented 1 additional patent pending natural Buckwheat Honey BEECure™ medical device which also demonstrated superior clinical outcomes. Studies have proven that buckwheat honey has superior medicinal properties to Manuka honey and other natural remedies. Our products also have higher standardization and broader spectrum anti-microbial activity achieving consistent clinical outcomes. Buckwheat honey also has higher anti-inflammatory and anti-oxidant activities than other products currently being used. 

Our patented advanced wound care (AWC) dressing will be the only product in the market that meets all the requirements of an ideal wound dressing, debridement, tissue repair, and anti-microbial properties. The anti-oxidant properties in Buckwheat honey assist in wound closure and help to stimulate the wound healing process. This means wounds are healing faster and better without the risk of further complications that could be a great hindrance to the lives of patients. Our Buckwheat honey patented formulation prevents life-threatening bacteria from penetrating through the dressing while it is in use. The nutrients in the honey help spur tissue regeneration because it contains large quantities of easily assailable sugars, amino acids, vitamins, specifically vitamin C. Our (AWC) products are made to heal chronic and difficult to close wounds.

This product is pending FDA approval.

Products in Use 

Our BEECure™ skin and wound care products are categorized into two business segments with each being formulated with the common ingredient of buckwheat honey. Our BEECure™ R -Radiation and Laser skin Care cream launched on Amazon in February 2021 and received the Amazon Choice award in the first month. Our advanced wound care products will also be used in hospitals and rehabilitation centers, by physicians through the use of dressings and ointments.

BEECure^® M is not currently available on the market. This product is pending 510(k) submission.

Because of the anticipated anti-microbial claim in our AWC dressings, they will be instrumental in the treatment and healing of:

• Ulcers, diabetic and otherwise
• Skin grafts
• Partial Thickness Burns
• Trauma and triage
• Surgical Site Infections

In addition to our AWC products, SanMelix buckwheat honey-based OTC Skin Care cream and ointments can be used for the treatment of:

• Radiation and Laser Skin Care
• Sunburns
• Minor burns
• Diabetic foot ulcer cream
• Acne
• Eczema 

The difference is in the ingredients 

Although manuka honey is the most commonly used honey-based wound treatment on the market, studies have shown that buckwheat honey has superior inherent healing properties when compared to manuka honey due to its higher anti-inflammatory and higher anti-oxidant activities. In addition, SanMelix’ s advanced wound care products have been fortified with antimicrobials to ensure a higher standardized and broader spectrum antibacterial activity. Our patented formulation utilized in our AWC dressings permits SanMelix to launch one of the first bioactive honey dressing to make an antimicrobial claim in the U.S. Our honey dressing is currently undergoing the FDA regulatory 510(k) clearance process. Our bioactive dressing will be for any wound type of any depth and severity. The dressing will prevent biofilms from forming, control wound odor, reduce pain and treatment time while being cost-effective and more environmentally sound. 

Additionally, there will be improved skin and tissue regeneration and debriding action. This prevents the necessity for excess skin grafts or skin substitutes, which run the added risk of infection or rejection. Studies have shown buckwheat honey has bactericidal activity against antibiotic-resistant pathogens. In addition, our 510(k) testing for BEECure™ M demonstrated the efficacy of our dressing against these super infections.

The bottom line is that our enhanced Buckwheat honey dressings and ointments are making the lives of patients and doctors easier. We are here to assist in the healing process and make a painful experience as painless as possible. We have seen firsthand the need for such products as the ones we have been creating and know that our BEECure^® products are going to be a big step forward in changing the lives of many. 

Our patented advanced wound care dressing will be the only product in the market that meets all the requirements of an ideal wound dressing, debridement, tissue repair, and anti-microbial properties.

Characteristics of an ideal wound dressing

Harnessing the power of nature and science with Buckwheat honey and calendula, SanMelix launched BEECure R radiation and laser skin care. These natural nutrients nourish and hydrate the skin, help restore elasticity and revive dry skin.

(source, source, source, source, source, source, source)

Our products have been proven to be safe & effective in early studies 

• We reached our crowdfunding goal of $1.07M, and have 1,725 investors on StartEngine
• We launched our BEECure ™ R-radiation and laser skin care on Amazon and Walmart.com
• We have completed testing on our advanced wound care products and will apply for 510(k) pre-market clearance from the FDA in Q3 2021
• We secured a secondary US honey supplier and purchased US manufacturer worldwide formulation rights for BEECure™ R -Radiation and Laser Skin Care which reduces our overall manufacturing cost
• We were granted 2 US patents and 1 Canadian patent and will continue prosecuting our other patent pending formulation application. US trademarks were issued in Q2 2021. Company has also filed an international trademark

Traction by year:

On top of this, we are negotiating with other cGMPs to contract manufacture our skin and wound care products. With the funds raised through StartEngine, we plan to complete an evidence-based clinical trial for widespread clinical adoption on our advanced wound care dressing and move to commercialization. Develop, test, and commercialize additional Skin and Wound Care OTC products as well as build up inventory. In addition, we will hire manufacturing, operations, and sales and marketing executives, while continuing to prosecute patents and trademarks. 

We are thrilled about the future opportunities that are in store for the SanMelix team and the effect our nature-based products will have on healing.

There are over 50 million reported cases globally of patients suffering from hard-to-close wounds. 15% of these are diabetic foot ulcers that eventually lead to amputation. With natural Buckwheat Honey, proven to have superior healing and skin care outcomes, at its core, BEECure™ is the only dressing to contain the three essential components of skin and wound care. Antioxidants to boost continuous healing, superior anti-bacterial properties for wound cleansing and heightened resistance against infections, and natural anti-inflammatory and humectant properties to soothe, regenerate and revitalize skin.

SanMelix BEECure™ bioactive skin and wound care products are here to treat everything from a minor scrape to a severe wound and everything in between. Using our unique enhanced Buckwheat honey patented formulations fortified with microbial barriers, we are treating all types of dermal afflictions by speeding up the healing process and reducing pain and the risk of infection. We will be first to market buckwheat honey skin and wound care products in the United States. Our patented advanced wound care dressing will assist with the complexities of combating Hospital Associated Infections (HAIs) across healthcare settings and in the community.

Honey is a product that has been used all throughout history as a healing and restorative agent, and we are harnessing its natural powers and using our years of scientific and medicinal studies to enhance it. We are regulating it to make it safe for hospital use, as well as selling it OTC to the average consumer. Everyone should be able to experience the benefits of the BEECure™ Buckwheat honey products. 

Our customers will include the VA & DoD, medical supply distributors, physician networks, hospitals, SNFs as well as indirect sales channel for private label/ white label for OTC opportunities. We will market directly to OTC consumers through the world wide web, pharmacies, retails stores, and indirect sales channel for private label/white label. We are capitalizing on a market that has been desperately in need of a natural and safe product that promotes healing and tissue growth while providing infection control. With our current traction and growth, we will continue to innovate new products and work on opening up key distribution regions across the country. To increase brand awareness, we have hired a successful sales advisor. We now have greater ability to create and design sales materials to engage in digital marketing

We have a talented and world-renowned physician group who puts patient care first. Our goal is to improve patients' lives in need of healing with our innovative bioactive skin and wound care products.

(Source, Source, Source, Source)